S8 Ep7: Blum Highlights Implications of CA-125 Levels in Renal Medullary Carcinoma

from OncLive® On Air · host OncLive® On Air

Dr Blum discusses renal medullary carcinoma, the lack of approved systemic therapy for these patients, and findings showing a correlation between CA-125 levels and increased tumor burden and treatment response in this disease.

Episode metadata supplied by the publisher feed · Published Dec 19, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

S8 Ep7: Blum Highlights Implications of CA-125 Levels in Renal Medullary Carcinoma

0:00 22:46

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OncLive® On Air?

This episode is 22 minutes long.

When was this OncLive® On Air episode published?

This episode was published on December 19, 2022.

Can I download this OncLive® On Air episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!